跳至主要内容
临床试验/JPRN-UMIN000032339
JPRN-UMIN000032339已完成4 期

Brexpiprazole for the treatment of acute schizophrenia in the Japanese population - Brexpiprazole for acute schizophrenia

Fujita Health University School of Medicine0 个研究点目标入组 100 人开始时间: 2018年4月21日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. the patient with coma 2. the patient receiving anesthetic agent or barbiturate 3. the patient receiving epinephrine 4. the patient receiving psychostimulant 5. the patient having allergy brexpiprazole 6, the patient with DM 7. the patient with pregnancy 8. the patient with breast-feeding 9. the patient receiving clozapine 10. the patient suitable for clozapine 11. the patient who the clinician do not suggest to entry the study 12. the patient with mental retardation 13. the patient with dementia 14. the patient with personality disorder 15. the patient with organic brain disease and/or severe physical disease 16. the patient receiving paroxetine 17. the patient receiving carbamazepine 18. the patient receiving electroconvulsive therapy within 6 months before the study 19. the patient receiving long-acting injectable antipsychotics within 6 months before the study

研究者

发起方
Fujita Health University School of Medicine

相似试验